VIFOR PHARMA, INC.
KING OF PRUSSIA, PA

VIFOR PHARMA, INC. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of polymer-based medicines designed to address often overlooked or undertreated medical conditions with serious impacts on patient lives or potential to be life-threatening. Following its foundation in October 2007, Relypsa became an integral part of VIFOR Pharma in September 2016, enhancing their focus on developing transformative treatments. Headquartered in Redwood City, California, the company has expanded its operations under the parent group known as Vifor Fresenius Medical Care Renal Pharma. In recent developments, Vifor Pharma has undertaken strategic steps including initiating the Submission of a Marketing Authorisation Application in Europe for Patiromer to treat hyperkalemia and signing an acquisition agreement with Soho Flordis International. Additionally, they have expanded their product portfolio and established marketing and sales organization within Europe. Previously known as Relypsa, Inc., the company continues to uphold a mission of innovation within the pharmaceutical domain, underlined by regulatory compliance, evidenced by its filing status as FORP with a Florida Corporate Identification number F15000005435. The last amendment event was recorded on March 2, 2021, and its annual reports are filed up to the year 2024. VIFOR PHARMA, INC. maintains open channels for medical information, drug safety concerns, adverse event reporting, and product quality complaints. With operations at 200 Cardinal Way, Redwood City, CA, Vifor Pharma can be contacted via multiple phone lines: (650) 421-9500, (844) 735-9772, and (844) 835-8277, facilitating engagement with stakeholders both professionally and medically. The company's leadership includes key figures such as Matthew Bocchino serving as Treasurer, Timothy Kanter as Vice President, and Alex Sigalas managing Secretarial duties. Vifor Pharma remains committed to enhancing patient outcomes through innovative medical solutions and strategic corporate growth.